Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Cantor Fitzgerald
Merck
Farmers Insurance
Boehringer Ingelheim
Daiichi Sankyo
Baxter
Harvard Business School
Mallinckrodt

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019991

« Back to Dashboard
NDA 019991 describes NOVOLIN 70/30, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. It is available from four suppliers. Additional details are available on the NOVOLIN 70/30 profile page.

The generic ingredient in NOVOLIN 70/30 is insulin recombinant human; insulin susp isophane recombinant human. There are thirty-eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the insulin recombinant human; insulin susp isophane recombinant human profile page.

Summary for NDA: 019991

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019991

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOVOLIN 70/30
insulin recombinant human; insulin susp isophane recombinant human
INJECTABLE;INJECTION 019991 NDA Novo Nordisk 0169-1837 0169-1837-02 1 VIAL in 1 CARTON (0169-1837-02) > 10 mL in 1 VIAL
NOVOLIN 70/30
insulin recombinant human; insulin susp isophane recombinant human
INJECTABLE;INJECTION 019991 NDA Novo Nordisk 0169-1837 0169-1837-11 1 VIAL in 1 CARTON (0169-1837-11) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:INJECTABLE;INJECTIONStrength30 UNITS/ML;70 UNITS/ML
Approval Date:Jun 25, 1991TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Moodys
Accenture
Daiichi Sankyo
Boehringer Ingelheim
Farmers Insurance
McKinsey
Baxter
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot